Navigation Links
Medtronic Infuse Bone Graft Questioned As Allegations Unfold – Bisnar | Chase Attorneys Offer Free Consultations
Date:7/3/2012

Newport Beach, California (PRWEB) July 03, 2012

According to a public health notification released by the FDA in July of 2008, Infuse bone graft products were used in procedures that the FDA did not grant approval for use with this product.

Senator Max Baucus has personally written a letter to Medtronic stating that "These reports that doctors conducting medical trials while on Medtronic’s payroll may have hidden serious side effects for patients are deeply troubling".

John Bisnar, managing partner of the Bisnar | Chase law firm, alleges that patients who have suffered injuries while utilizing the Infuse Bone Graft devices may be eligible for compensation.

According to Medtronic’s numbers, 500,000 patients have been treated with the Infuse Bone Graft product. The product was designed to assist in the treatment of degenerative disc disease (DDD).

Infuse (recombinant human Bone Morphogenetic Protein-2, rhBMP) is a genetically engineered protein that would normally be found naturally in one’s body. Medtronic claims that if it is used properly, one can stimulate bone formation and avoid additional surgeries during treatment.

The FDA's 2008 public health notification stated that reports had been received associating life-threatening complications with rhBMP when used in the cervical spine. The notification went on to say that “the safety and effectiveness of rhBMP in the cervical spine have not been demonstrated and these products are not approved by the FDA for this use.”

The numbers released by the FDA in their public health notification included 38 reports detailing complications when using Infuse Bone Graft products in cervical spine fusion. Similar complications were reported including swelling of the throat tissue and compression of the airway. Some patients had difficulty speaking, swallowing, and breathing.

According to the Journal Sentinel's June 27th Watchdog Report, a number of complications were associated with use of the Infuse Bone Graft product amongst human trial participants between 2000 and 2009. The report alleges that the Medtronic sponsored trials were conducted by physicians that failed to report the severity of the side effects sustained by the participants.

The doctors associated with the Medtronic Infuse Bone Graft clinical trials stated that "Although not desirable, bone formation in the spinal canal does not appear to have a discernible effect on patient outcomes." "Even though bone formed, no negative outcomes were found," according to the Journal Sentinel.

Reports to the FDA, cited in and leading to their public health notification, produced evidence to the contrary.

Brian Chase, Infuse Bone Graft attorney, has been assisting defective product victims for decades. Mr. Chase has observed first-hand the devastation that product defect victims undergo following the negligence of large corporations.

“Too often, large companies produce products without their consumer’s safety in mind. Product defect victims do not want to believe that businesses may be operated by people who place the priority of their profit margins above their consumer’s level of safety.”

“When manufacturers fail to provide a reasonable level of safety for those who use their products, victims have a right to pursue compensation for their medical expenses, as well as any pain and suffering that may have been caused”, says Brian Chase.

About: Bisnar | Chase, Infuse Bone Graft Lawyers, Orange County, CA

Bisnar | Chase is an Orange County, California based defective product law firm that has developed a reputation as trusted professionals delivering outstanding results. Brian Chase, senior partner, has obtained several multimillion dollar verdicts and settlements on behalf of his product defect clients, including a 24.7 million dollar verdict in August of 2011.

Bisnar | Chase attorneys assist product defect victims throughout the United States.

For matters involving defective products, contact the Bisnar | Chase Infuse Bone Graft lawyers at 800-561-4887 or visit their website at http://www.bestattorney.com/california-class-action-attorneys.html.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9663343.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
2. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
3. Donor aortic graft improves reconstruction after partial laryngectomy
4. Fish Oil Doesnt Cut Failure Rate of Hemodialysis Grafts
5. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
6. IOC Takes Decisive Action on Ticketing Allegations
7. Prions and cancer: A story unfolding
8. From herd immunity and complacency to group panic: How vaccine scares unfold
9. Fox Chase researchers find no disparities in imaging before breast cancer surgery
10. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
11. Mesothelioma Victims Center Now Urges US Navy Veterans Or Individuals With Mesothelioma To Call Them For The Names Of The Best Mesothelioma Attorneys & Treatment Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: